<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery</title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Title</span></td>
               <td width="80%" colspan="3">Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Identifier<br>(Measure Authoring Tool)</span></td>
               <td width="30%">133</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Version number</span></td>
               <td width="30%">1</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">NQF Number</span></td>
               <td width="30%">0565</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">GUID</span></td>
               <td> 39e0424a-1727-4629-89e2-c46c2fbb3f5f</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td width="80%" colspan="3">January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Developer</span></td>
               <td width="80%" colspan="3">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Developer</span></td>
               <td width="80%" colspan="3">National Committee for Quality Assurance</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed By</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved within 90 days following the cataract surgery.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Copyright 2012 American Medical Association and National Committee for Quality Assurance. All Rights Reserved.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Disclaimer</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement(R) (the PCPI[TM]) and the National Committee for Quality Assurance (NCQA). These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI) or NCQA. Neither the AMA, NCQA, PCPI nor its members shall be responsible for any use of the Measures. 

THE MEASURES AND SPECIFICATIONS ARE PROVIDED &#8220;AS IS&#8221; WITHOUT WARRANTY OF ANY KIND. 

Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, NCQA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications. 

CPT(R) contained in the Measure specifications is copyright 2004-2011 American Medical Association. LOINC(R) copyright 2004-2011 Regenstrief Institute, Inc. 
This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2011 International Health Terminology Standards Development Organisation. ICD-10 Copyright 2011 World Health Organization. All Rights Reserved.

Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Type</span></td>
               <td width="80%" colspan="3">Outcome</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rate Aggregation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>1. Scientific basis for measuring visual acuity outcomes after cataract surgery
The only reason to perform cataract surgery (other than for a limited set of medical indications) is to improve a patient&#8217;s vision and associated functioning. The use of a 20/40 visual acuity threshold is based on several considerations. First, it is the level for unrestricted operation of a motor vehicle in the US. Second, it has been consistently used by the FDA in its assessment for approval of intraocular lens (IOL) and other vision devices. Third, it is the literature standard to denote success in cataract surgery. Fourth, work by West et al in the Salisbury Eye Study suggests that 20/40 is an useful threshold for 50th percentile functioning for several vision-related tasks.
Most patients achieve excellent visual acuity after cataract surgery (20/40 or better). This outcome is achieved consistently through careful attention through the accurate measurement of axial length and corneal power and the appropriate selection of an IOL power calculation formula. As such, it reflects the care and diligence with which the surgery is assessed, planned and executed. Failure to achieve this after surgery in eyes without comorbid ocular conditions that would impact the success of the surgery would reflect care that should be assessed for opportunities for improvement.
The exclusion of patients with other ocular and systemic conditions known to increase the risk of an adverse outcome reflects the findings of the two published prediction rule papers for cataract surgery outcomes, by Mangione et al. and Steinberg et al. In both papers, the presence of comorbid glaucoma and macular degeneration negatively impacted the likelihood of successful outcomes of surgery. Further, as noted in the prior indicator, exclusion of eyes with ocular conditions that could impact the success of the surgery would NOT eliminate the large majority of eyes undergoing surgery while also minimizing the potential adverse selection that might otherwise occur relative to those patients with the most complex situations who might benefit the most from having surgery to maximize their remaining vision. Use of this indicator in the PQRI program would require some modification to the current reporting of post-operative care for patients undergoing cataract surgery, since this indicator would be operative during the 90 day global period. However, there is a strong and practical precedent for such modifications in that reporting arrangements have previously been made to accommodate co-management of care by different providers during the post-operative period. A similar adjustment to allow for filing of a claim of meeting this goal at one point in the 90 day global period would be sufficient, potentially drawing upon the methods to demarcate the onset of co-management transfer of post-operative care.

2. Evidence of a gap in care
This is an outcome of surgery indicator of direct relevance to patients and referring providers. The available evidence suggests that cataract surgery achieves this in between 86 and 98% of surgeries in eyes without comorbid ocular conditions (this indicator). While small, the volume of cataract surgery in the US of over 2.8 million surgeries suggests that the impact could affect more than 100,000 patients per year. Because of the exclusion of comorbid ocular conditions, one would expect performance on this indicator to be as high as possible, with significantly lower rates suggestive of opportunities for improvement.
The ASCRS National Cataract Database reported that at 3 months postoperatively, 85.5% of all patients had a 20/40 or better best-corrected visual acuity, 57.2% of patients had 20/25 or better postoperative best-corrected visual acuity, and 74.6% of patients were within +/- 1.0 D of target spherical equivalent. Based on 5,788 responses, the mean visual function index score at 3 months postoperatively was 70.3% compared with 55.0% preoperatively. (The score is based on a scale of 0 to 100, with 0 indicating an inability to perform any of the activities.) The European Cataract Outcome Study reported for 1999 that 89% of patients achieved a postoperative visual acuity of 0.5 or more (20/40 or better), the average induced astigmatism was 0.59 D, and 86% of patients had an induced astigmatism within +/- 1.0 D.

The AAO National Eyecare Outcomes Network (NEON) database also found similar rates of success, with an improvement in visual acuity in 92.2% of patients and improvement in VF-14 in over 90% of patients. Best-corrected visual acuity (BCVA) of 20/40 was achieved by 89% of all NEON patients and 96% of NEON patients without preoperative ocular comorbid conditions. Seventy-eight percent of patients were within +/-1.0 D of target spherical equivalent. Ninety-five percent of patients reported being satisfied with the results of their surgery. Patients who were dissatisfied with the results of their surgery were slightly older and more likely to have ocular comorbidity.

In studies of phacoemulsification cataract surgery performed by ophthalmology residents, the reported range of patients with postoperative BCVA of 20/40 or better is 80% to 91%. If eyes with ocular comorbidities are excluded, the reported range of patients with postoperative BCVA of 20/40 or better is 86% to 98%.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>This is an outcome measure. As such, no statements in the guideline are specific to this measurement topic.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement Notation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Higher score indicates better quality.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Albanis CV, Dwyer MA, Ernest JT. Outcomes of extracapsular cataract extraction and phacoemulsification performed in a university training program. Ophthalmic Surg Lasers 1998;29:643-8.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Blomquist PH, Rugwani RM. Visual outcomes after vitreous loss during cataract surgery performed by residents. J Cataract Refract Surg 2002;28:847-52.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Corey RP, Olson RJ. Surgical outcomes of cataract extractions performed by residents using phacoemulsification. J Cataract Refract Surg 1998;24:66-72.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Karp KO, Albanis CV, Pearlman JB, Goins KM. Outcomes of temporal clear cornea versus superior scleral tunnel phacoemulsification incisions in a university training program. Ophthalmic Surg Lasers. 2001;32:228-232.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Randleman JB, Srivastava SK, Aaron MM. Phacoemulsification with topical anesthesia performed by resident surgeons. J Cataract Refract Surg. 2004;30:149-154.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Tarbet KJ, et al. Complications and results of phacoemulsification performed by residents. J Cataract Refract Surg. 1995;21:661-665.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Quillen DA, Phipps SJ. Visual outcomes and incidence of vitreous loss for residents performing phacoemulsification without prior planned extracapsular cataract extraction experience. Am J Ophthalmol. 2003;135:732-733.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>The unit of analysis for this measure is each cataract procedure, including instances where more than one cataract procedure was performed during the measurement performed.  Only procedures performed during January 1-September 30 of the reporting period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure.  Cataract procedures performed during October 1 &#8211; December 31 are excluded from the initial patient population.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Transmission Format</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>TBD</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Initial Patient Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>All patients aged 18 years and older who had cataract surgery</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Equals Initial Patient Population</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Patients with specified comorbid conditions that impact the visual outcome of surgery</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Patients who had best-corrected visual acuity of 20/40 or better (distance or near) achieved within 90 days following cataract surgery</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exceptions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Observations</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</pre></div>
               </td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d2757272e546">Population criteria</a></li>
         <li><a href="#d2757272e2995">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d2757272e5270">Reporting Stratification</a></li>
         <li><a href="#d2757272e5291">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d2757272e546" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic Birthdate: birth date"  &gt;= 18 year(s) starts before start of "Measurement Period"</li>
                  <li>AND: "Occurrence A of Procedure, Performed: Cataract Surgery" during "Measurement Period"</li>
                  <li>AND: "Occurrence A of Procedure, Performed: Cataract Surgery"  &gt; 92 day(s) starts before start of "Measurement End Date"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: "Diagnosis, Active: Acute and Subacute Iridocyclitis"</li>
                        <li>OR: "Diagnosis, Active: Pathologic Myopia"</li>
                        <li>OR: "Diagnosis, Active: Cloudy Cornea"</li>
                        <li>OR: "Diagnosis, Active: Scleritis and Episcleritis"</li>
                        <li>OR: "Diagnosis, Active: Disorders of Visual Cortex"</li>
                        <li>OR: "Diagnosis, Active: Optic Atrophy"</li>
                        <li>OR: "Diagnosis, Active: Other Endophthalmitis"</li>
                        <li>OR: "Diagnosis, Active: Separation of Retinal Layers"</li>
                        <li>OR: "Diagnosis, Active: Diabetic Retinopathy"</li>
                        <li>OR: "Diagnosis, Active: Visual Field Defects"</li>
                        <li>OR: "Diagnosis, Active: Retinal Detachment with Retinal Defect"</li>
                        <li>OR: "Diagnosis, Active: Retinal Vascular Occlusion"</li>
                        <li>OR: "Diagnosis, Active: Purulent Endophthalmitis"</li>
                        <li>OR: "Diagnosis, Active: Certain Types of Iridocyclitis"</li>
                        <li>OR: "Diagnosis, Active: Glaucoma Associated with Congenital Anomalies, Dystrophies, and Systemic Syndromes"</li>
                        <li>OR: "Diagnosis, Active: Chronic Iridocyclitis"</li>
                        <li>OR: "Diagnosis, Active: Choroidal Degenerations"</li>
                        <li>OR: "Diagnosis, Active: Optic Neuritis"</li>
                        <li>OR: "Diagnosis, Active: Other Background Retinopathy and Retinal Vascular Changes"</li>
                        <li>OR: "Diagnosis, Active: Other Corneal Deformities"</li>
                        <li>OR: "Diagnosis, Active: Other Retinal Disorders"</li>
                        <li>OR: "Diagnosis, Active: Prior Penetrating Keratoplasty"</li>
                        <li>OR: "Diagnosis, Active: Other and Unspecified forms of Chorioretinitis and Retinochoroiditis"</li>
                        <li>OR: "Diagnosis, Active: Amblyopia"</li>
                        <li>OR: "Diagnosis, Active: Corneal Edema"</li>
                        <li>OR: "Diagnosis, Active: Nystagmus and other Irregular Eye Movements"</li>
                        <li>OR: "Diagnosis, Active: Moderate or Severe Impairment, Better Eye, Profound Impairment Lesser Eye"</li>
                        <li>OR: "Diagnosis, Active: Hereditary Choroidal Dystrophies"</li>
                        <li>OR: "Diagnosis, Active: Hereditary Retinal Dystrophies"</li>
                        <li>OR: "Diagnosis, Active: Burn Confined to Eye and Adnexa"</li>
                        <li>OR: "Diagnosis, Active: Other Disorders of Sclera"</li>
                        <li>OR: "Diagnosis, Active: Focal Chorioretinitis and Focal Retinochoroiditis"</li>
                        <li>OR: "Diagnosis, Active: Degenerative Disorders of Globe"</li>
                        <li>OR: "Diagnosis, Active: Degeneration of Macula and Posterior Pole"</li>
                        <li>OR: "Diagnosis, Active: Disseminated Chorioretinitis and Disseminated Retinochoroiditis"</li>
                        <li>OR: "Diagnosis, Active: Diabetic Macular Edema"</li>
                        <li>OR: "Diagnosis, Active: Uveitis"</li>
                        <li>OR: "Diagnosis, Active: Profound Impairment, Both Eyes"</li>
                        <li>OR: "Diagnosis, Active: Other Proliferative Retinopathy"</li>
                        <li>OR: "Diagnosis, Active: Cataract Secondary to Ocular Disorders"</li>
                        <li>OR: "Diagnosis, Active: Choroidal Detachment"</li>
                        <li>OR: "Diagnosis, Active: Disorders of Optic Chiasm"</li>
                        <li>OR: "Diagnosis, Active: Injury to Optic Nerve and Pathways"</li>
                        <li>OR: "Diagnosis, Active: Choroidal Hemorrhage and Rupture"</li>
                        <li>OR: "Diagnosis, Active: Other Disorders of Optic Nerve"</li>
                        <li>OR: "Diagnosis, Active: Glaucoma"</li>
                        <li>OR: "Diagnosis, Active: Chorioretinal Scars"</li>
                        <li>OR: "Diagnosis, Active: Hereditary Corneal Dystrophies"</li>
                        <li>OR: "Diagnosis, Active: Central Corneal Ulcer"</li>
                        <li>OR: "Diagnosis, Active: Corneal Opacity and other Disorders of Cornea"</li>
                        <li>OR: "Diagnosis, Active: Open Wound of Eyeball"</li>
                        <li> starts before start of "Occurrence A of Procedure, Performed: Cataract Surgery"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Numerator =</b>
               
               <ul>
                  <li>AND: "Diagnostic Study, Result: Visual acuity 20/40 or Better"  &lt;= 90 day(s) starts after end of "Occurrence A of Procedure,
                     Performed: Cataract Surgery"
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d2757272e2995" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: Acute and Subacute Iridocyclitis" using "Acute and Subacute Iridocyclitis Grouping Value Set (2.16.840.1.113883.3.526.3.1241)"
            </li>
            <li>
               "Diagnosis, Active: Amblyopia" using "Amblyopia Grouping Value Set (2.16.840.1.113883.3.526.3.1448)"
            </li>
            <li>
               "Diagnosis, Active: Burn Confined to Eye and Adnexa" using "Burn Confined to Eye and Adnexa Grouping Value Set (2.16.840.1.113883.3.526.3.1409)"
            </li>
            <li>
               "Diagnosis, Active: Cataract Secondary to Ocular Disorders" using "Cataract Secondary to Ocular Disorders Grouping Value Set (2.16.840.1.113883.3.526.3.1410)"
            </li>
            <li>
               "Diagnosis, Active: Central Corneal Ulcer" using "Central Corneal Ulcer Grouping Value Set (2.16.840.1.113883.3.526.3.1428)"
            </li>
            <li>
               "Diagnosis, Active: Certain Types of Iridocyclitis" using "Certain Types of Iridocyclitis Grouping Value Set (2.16.840.1.113883.3.526.3.1415)"
            </li>
            <li>
               "Diagnosis, Active: Chorioretinal Scars" using "Chorioretinal Scars Grouping Value Set (2.16.840.1.113883.3.526.3.1449)"
            </li>
            <li>
               "Diagnosis, Active: Choroidal Degenerations" using "Choroidal Degenerations Grouping Value Set (2.16.840.1.113883.3.526.3.1450)"
            </li>
            <li>
               "Diagnosis, Active: Choroidal Detachment" using "Choroidal Detachment Grouping Value Set (2.16.840.1.113883.3.526.3.1451)"
            </li>
            <li>
               "Diagnosis, Active: Choroidal Hemorrhage and Rupture" using "Choroidal Hemorrhage and Rupture Grouping Value Set (2.16.840.1.113883.3.526.3.1452)"
            </li>
            <li>
               "Diagnosis, Active: Chronic Iridocyclitis" using "Chronic Iridocyclitis Grouping Value Set (2.16.840.1.113883.3.526.3.1416)"
            </li>
            <li>
               "Diagnosis, Active: Cloudy Cornea" using "Cloudy Cornea Grouping Value Set (2.16.840.1.113883.3.526.3.1417)"
            </li>
            <li>
               "Diagnosis, Active: Corneal Edema" using "Corneal Edema Grouping Value Set (2.16.840.1.113883.3.526.3.1418)"
            </li>
            <li>
               "Diagnosis, Active: Corneal Opacity and other Disorders of Cornea" using "Corneal Opacity and other Disorders of Cornea Grouping Value Set (2.16.840.1.113883.3.526.3.1419)"
            </li>
            <li>
               "Diagnosis, Active: Degeneration of Macula and Posterior Pole" using "Degeneration of Macula and Posterior Pole Grouping Value Set (2.16.840.1.113883.3.526.3.1453)"
            </li>
            <li>
               "Diagnosis, Active: Degenerative Disorders of Globe" using "Degenerative Disorders of Globe Grouping Value Set (2.16.840.1.113883.3.526.3.1454)"
            </li>
            <li>
               "Diagnosis, Active: Diabetic Macular Edema" using "Diabetic Macular Edema Grouping Value Set (2.16.840.1.113883.3.526.3.1455)"
            </li>
            <li>
               "Diagnosis, Active: Diabetic Retinopathy" using "Diabetic Retinopathy Grouping Value Set (2.16.840.1.113883.3.526.3.327)"
            </li>
            <li>
               "Diagnosis, Active: Disorders of Optic Chiasm" using "Disorders of Optic Chiasm Grouping Value Set (2.16.840.1.113883.3.526.3.1457)"
            </li>
            <li>
               "Diagnosis, Active: Disorders of Visual Cortex" using "Disorders of Visual Cortex Grouping Value Set (2.16.840.1.113883.3.526.3.1458)"
            </li>
            <li>
               "Diagnosis, Active: Disseminated Chorioretinitis and Disseminated Retinochoroiditis" using "Disseminated Chorioretinitis and Disseminated Retinochoroiditis Grouping Value Set (2.16.840.1.113883.3.526.3.1459)"
            </li>
            <li>
               "Diagnosis, Active: Focal Chorioretinitis and Focal Retinochoroiditis" using "Focal Chorioretinitis and Focal Retinochoroiditis Grouping Value Set (2.16.840.1.113883.3.526.3.1460)"
            </li>
            <li>
               "Diagnosis, Active: Glaucoma" using "Glaucoma Grouping Value Set (2.16.840.1.113883.3.526.3.1423)"
            </li>
            <li>
               "Diagnosis, Active: Glaucoma Associated with Congenital Anomalies, Dystrophies, and Systemic Syndromes" using "Glaucoma Associated with Congenital Anomalies, Dystrophies, and Systemic Syndromes Grouping Value Set (2.16.840.1.113883.3.526.3.1461)"
            </li>
            <li>
               "Diagnosis, Active: Hereditary Choroidal Dystrophies" using "Hereditary Choroidal Dystrophies Grouping Value Set (2.16.840.1.113883.3.526.3.1462)"
            </li>
            <li>
               "Diagnosis, Active: Hereditary Corneal Dystrophies" using "Hereditary Corneal Dystrophies Grouping Value Set (2.16.840.1.113883.3.526.3.1424)"
            </li>
            <li>
               "Diagnosis, Active: Hereditary Retinal Dystrophies" using "Hereditary Retinal Dystrophies Grouping Value Set (2.16.840.1.113883.3.526.3.1463)"
            </li>
            <li>
               "Diagnosis, Active: Injury to Optic Nerve and Pathways" using "Injury to Optic Nerve and Pathways Grouping Value Set (2.16.840.1.113883.3.526.3.1427)"
            </li>
            <li>
               "Diagnosis, Active: Moderate or Severe Impairment, Better Eye, Profound Impairment Lesser Eye" using "Moderate or Severe Impairment, Better Eye, Profound Impairment Lesser Eye Grouping Value Set (2.16.840.1.113883.3.526.3.1464)"
            </li>
            <li>
               "Diagnosis, Active: Nystagmus and other Irregular Eye Movements" using "Nystagmus and other Irregular Eye Movements Grouping Value Set (2.16.840.1.113883.3.526.3.1465)"
            </li>
            <li>
               "Diagnosis, Active: Open Wound of Eyeball" using "Open Wound of Eyeball Grouping Value Set (2.16.840.1.113883.3.526.3.1430)"
            </li>
            <li>
               "Diagnosis, Active: Optic Atrophy" using "Optic Atrophy Grouping Value Set (2.16.840.1.113883.3.526.3.1466)"
            </li>
            <li>
               "Diagnosis, Active: Optic Neuritis" using "Optic Neuritis Grouping Value Set (2.16.840.1.113883.3.526.3.1467)"
            </li>
            <li>
               "Diagnosis, Active: Other and Unspecified forms of Chorioretinitis and Retinochoroiditis" using "Other and Unspecified forms of Chorioretinitis and Retinochoroiditis Grouping Value Set (2.16.840.1.113883.3.526.3.1468)"
            </li>
            <li>
               "Diagnosis, Active: Other Background Retinopathy and Retinal Vascular Changes" using "Other Background Retinopathy and Retinal Vascular Changes Grouping Value Set (2.16.840.1.113883.3.526.3.1469)"
            </li>
            <li>
               "Diagnosis, Active: Other Corneal Deformities" using "Other Corneal Deformities Grouping Value Set (2.16.840.1.113883.3.526.3.1470)"
            </li>
            <li>
               "Diagnosis, Active: Other Disorders of Optic Nerve" using "Other Disorders of Optic Nerve Grouping Value Set (2.16.840.1.113883.3.526.3.1471)"
            </li>
            <li>
               "Diagnosis, Active: Other Disorders of Sclera" using "Other Disorders of Sclera Grouping Value Set (2.16.840.1.113883.3.526.3.1472)"
            </li>
            <li>
               "Diagnosis, Active: Other Endophthalmitis" using "Other Endophthalmitis Grouping Value Set (2.16.840.1.113883.3.526.3.1473)"
            </li>
            <li>
               "Diagnosis, Active: Other Proliferative Retinopathy" using "Other Proliferative Retinopathy Grouping Value Set (2.16.840.1.113883.3.526.3.1480)"
            </li>
            <li>
               "Diagnosis, Active: Other Retinal Disorders" using "Other Retinal Disorders Grouping Value Set (2.16.840.1.113883.3.526.3.1474)"
            </li>
            <li>
               "Diagnosis, Active: Pathologic Myopia" using "Pathologic Myopia Grouping Value Set (2.16.840.1.113883.3.526.3.1432)"
            </li>
            <li>
               "Diagnosis, Active: Prior Penetrating Keratoplasty" using "Prior Penetrating Keratoplasty Grouping Value Set (2.16.840.1.113883.3.526.3.1475)"
            </li>
            <li>
               "Diagnosis, Active: Profound Impairment, Both Eyes" using "Profound Impairment, Both Eyes Grouping Value Set (2.16.840.1.113883.3.526.3.1476)"
            </li>
            <li>
               "Diagnosis, Active: Purulent Endophthalmitis" using "Purulent Endophthalmitis Grouping Value Set (2.16.840.1.113883.3.526.3.1477)"
            </li>
            <li>
               "Diagnosis, Active: Retinal Detachment with Retinal Defect" using "Retinal Detachment with Retinal Defect Grouping Value Set (2.16.840.1.113883.3.526.3.1478)"
            </li>
            <li>
               "Diagnosis, Active: Retinal Vascular Occlusion" using "Retinal Vascular Occlusion Grouping Value Set (2.16.840.1.113883.3.526.3.1479)"
            </li>
            <li>
               "Diagnosis, Active: Scleritis and Episcleritis" using "Scleritis and Episcleritis Grouping Value Set (2.16.840.1.113883.3.526.3.1481)"
            </li>
            <li>
               "Diagnosis, Active: Separation of Retinal Layers" using "Separation of Retinal Layers Grouping Value Set (2.16.840.1.113883.3.526.3.1482)"
            </li>
            <li>
               "Diagnosis, Active: Uveitis" using "Uveitis Grouping Value Set (2.16.840.1.113883.3.526.3.1444)"
            </li>
            <li>
               "Diagnosis, Active: Visual Field Defects" using "Visual Field Defects Grouping Value Set (2.16.840.1.113883.3.526.3.1446)"
            </li>
            <li>
               "Diagnostic Study, Result: Visual acuity 20/40 or Better" using "Visual acuity 20/40 or Better Grouping Value Set (2.16.840.1.113883.3.526.3.1483)"
            </li>
            <li>
               "Patient Characteristic Birthdate: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
            <li>
               "Procedure, Performed: Cataract Surgery" using "Cataract Surgery Grouping Value Set (2.16.840.1.113883.3.526.3.1411)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d2757272e5270" href="#toc">Reporting Stratification</a></h3>
      <div>
         
         <ul>
            <li>None</li>
         </ul>
         
      </div>
      <h3><a name="d2757272e5291" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>
               "Patient Characteristic Ethnicity: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"
            </li>
            <li>
               "Patient Characteristic Payer: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.114222.4.11.3591)"
            </li>
            <li>
               "Patient Characteristic Race: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"
            </li>
            <li>
               "Patient Characteristic Sex: ONC Administrative Sex" using "ONC Administrative Sex Administrative Sex Value Set (2.16.840.1.113762.1.4.1)"
            </li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Set</span></td>
               <td colspan="3" width="80%">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto;word-wrap:break-word">Not Applicable</div>
               </td>
            </tr>
         </tbody>
      </table>
   </body>
</html>